share_log

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Sollis Gary

SEC ·  Mar 29 00:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more